Sentences with phrase «increasing epipen»

A lot of that growth came from increasing EpiPen prescriptions as the product became more mainstream: In the first seven years Mylan owned EpiPen, the number of patients using it grew 67 %, according to Bloomberg.

Furthermore, Bresch said increasing EpiPen access through school programs provided a social good that warranted a fair return.

Not exact matches

Mylan drew major flak last year after news broke that it had steadily increased the list price for an EpiPen two - pack from about $ 100 to more than $ 600 in less than a decade.

As lawmakers and the public scrutinize dramatic price increases for other old drugs — most recently with the Mylan - owned EpiPen, which saw its cost go up by 500 % in the past nine years — the next flash point may be insulin, a drug both ubiquitous and complicated.

Mylan, one of the 10 most heavily weighted stocks in the ETF, traded more than 1.5 percent higher despite recent political pressure over the stark price increases of its life - saving EpiPen device.

Since late August, when the EpiPen price increases came into the spotlight, Mylan shares have fallen about 15 %.

A test for the shares looms on Wednesday, when Mylan CEO Heather Bresch testifies before the U.S. House of Representatives Oversight Committee over price increases of EpiPen, an auto - injector of allergy medicine.

After all, Mylan acquired the EpiPen from another company, and while Bresch insists that significant improvements have been made to the epinephrine - delivering product itself, she also admitted on Thursday that a big part of the price increase rationale was to fund marketing and awareness efforts for the device.

On Wednesday, the Senate Special Committee on Aging, which has investigated price increases by Valeant (vrx) and other drugmakers, sent its own letter to Bresch demanding information about the EpiPen's pricing and market share since 2007.

In the first year Mylan owned EpiPen, its price increased nearly 5 %, to about $ 99 for a set of two EpiPens.

While the drug maker has responded to the massive backlash over its extravagant price increase on the device by boosting its patient assistance programs and introducing an authorized generic EpiPen version at half the cost, CVS» topline price will still be significantly cheaper.

Her comments came shortly after the Senate Committee on Aging asked Mylan to provide information on the reasoning behind what it called the «drastic» price increase of EpiPen, and the American Medical Association «urge [d]» Mylan to «rein in these exorbitant costs.»

In total, that amounts to a more than six-fold increase in the wholesale price of EpiPen since Mylan bought it.

She said that employers» increased use of high - deductible plans, one of the side - effects of the law, has resulted in patients paying more out of pocket for the drug, and that's «where you're seeing a lot of noise around EpiPen.»

But the following year, in 2009, the wholesale acquisition price of EpiPen jumped 26 %; since 2012, prices have increased almost 30 % each year.

Noting that Mylan had sought legislation to increase the number of patients who receive prescriptions for EpiPens, Rep. Mick Mulvaney, R-S.C.

Mylan Labs (MYLN) in the hot seat after they increased the price of the life saving EpiPen.

The interest intensified in 2016, when Mylan increased the cost of the EpiPen by 400 percent.

Chicago Public Schools is simultaneously increasing its awareness of the dangers of severe allergies and stocking more of the EpiPen shots used to treat them this academic year.

The increased price for the EpiPen — hike by some 400 percent — has led to bipartisan outrage toward Mylan as a generic version may soon be offered and calls for federal and state investigations grow.

Lt. Brian Falise of the Syracuse Fire Department said the reason for the switch is because there has been a steady increase in the price of EpiPens over the past few years.

Democratic Missouri U.S. Sen. Claire McCaskill said she expects Congress to hold hearings on the EpiPen price increases.

ALBANY, N.Y. (AP)-- The state attorney general's office is investigating whether Mylan Pharmaceuticals unfairly limited competition for its emergency allergy treatment EpiPen, which has been criticized for steep price increases.

«Given the recent unconscionable price increases of EpiPens by Mylan Pharmaceutical, we must look to more affordable alternatives for families dealing with allergies,» Hannon said in a statement.

The state attorney general's office is investigating whether Mylan Pharmaceuticals unfairly limited competition for its emergency allergy treatment EpiPen, which has been criticized for steep price increases.

«Some Americans who are unable to afford this cost increase have resorted to carrying expired EpiPens — or carry no EpiPens at all.»

There is much outrage over the increase in EpiPen pricing from the internet as well as from the patients that need the life - saving medication.